KS

Kathryn Swintek

Managing Partner, Golden Seeds, Independent Board Member, NACD Private Company Director of the Year 2020, Audit Committee

St Petersburg, Florida

Work Experience

  • Elected Member, Board of Trustees

    2024

    A jewel in Florida Suncoast's St. Petersburg, The Dali Museum, founded in 1982 is lauded by architecture critics for its distinctive building which houses the largest collection of works by Salvador Dali outside of Spain. Recognized for its innovative use of technology and for its Innovation Labs at the Dali, the museum is the only one in the American South to be awarded three Michelin stars.

2016

  • Member, Board of Directors

    2016

    Oculogica is a medical device company whose flagship product EyeBOX represents revolutionary technology using neuroscience and proprietary algorithms based on cranial nerve control of eye movements to aid diagnosis of concussion and the larger universe of TBI. The first and only baseline-free FDA-cleared device.

  • Member, Board of Directors

    2017

    ABI provides retail, mid market, and corporate banking products and services in Albania.

  • Managing Partner

    2010

    Golden Seeds Fund 2 invests in early stage companies in the life sciences, technology, software and e commerce sectors, preferring companies with gender diversity in ownership and management.

  • Member Board of Directors

    2010

    Ranked among the 50 largest women owned businesses in the United States, Turtle is a leading provider of electrical and industrial distribution, logistics, and holistic supply chain solutions.

  • Member Board of Directors

    2011 - 2021

    Technology-driven marketing services company serving the media industry.

  • Member Board of Directors and Chair, Audit Committee; Member Compensation Committee

    2013 - 2018

    Medical technology company offering innovative products for diagnosis and treatment of serious dermatological disorders.

  • Member Board of Directors

    2014 - 2017

    Medical device company in wound care segment which developed an FDA 510K cleared patented product and is in commercialization stage.

1989 - 2008

  • Managing Director

    1989 - 2008

    Headed Structured Finance Group for BNP in the U.S. Founded Global High Yield Bond Group for BNP Paribas Headed Leveraged Finance Group for BNP Paribas, North America Management Committee, BNP Paribas North America

1974 - 1989

  • SVP, Head of Acquisition Finance

    1974 - 1989

    At predecessor firm Irving Trust Company, merged with Bank of New York in 1989: Representative for France, Paris; Banking Officer, Middle East & North Africa Division; Senior Corporate Credit Officer